Quantcast

Latest Prostate Stories

2014-08-21 12:29:55

WASHINGTON, Aug. 21, 2014 /PRNewswire-USNewswire/ -- ZERO - The End of Prostate Cancer is hosting 16 run/walk events across the nation during September, Prostate Cancer Awareness Month, to raise funds and awareness to end prostate cancer, a disease that affects one in seven American men. http://photos.prnewswire.com/prnvar/20130129/DC50244LOGO "Thousands are making a choice for a healthy lifestyle and celebrating Prostate Cancer Awareness Month by walking or running," ZERO CEO Jamie...

2014-08-06 08:31:58

Study Achieved Primary Endpoint of Predicting Recurrence after Surgery and Reconfirmed Original Adverse Pathology Endpoint from Published UCSF Validation Study REDWOOD CITY, Calif., Aug. 6, 2014 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced positive preliminary results from an additional independent clinical validation study conducted by the Center for Prostate Disease Research (CPDR) demonstrating that the Oncotype DX(®) Genomic Prostate Score (GPS) predicts...

2014-08-05 12:31:41

Active Surveillance Provides Low-Risk Patients Less Harmful Treatment Option NORTHFIELD, Ill., Aug. 5, 2014 /PRNewswire-USNewswire/ -- Prostate cancer is the second leading cause of cancer death in men in the United States. Active surveillance offers low-risk prostate cancer patients a means to avoid the potentially harmful side effects from treatment. Pathologists help determine patient eligibility for active surveillance and today a multi-specialty team published their recommendations for...

2014-08-05 08:28:20

Demands Manufacturers Prove Claims of Safety and Benefits For Prostate Cancer Treatments CORAL SPRINGS, Fla., Aug. 5, 2014 /PRNewswire/ -- A prominent Florida prostate cancer specialist is leading a groundswell of physicians and prostate cancer patients challenging the efficacy of a popular robotic surgical treatment marketed and promoted into near ubiquitous use in hospitals across the nation. In an extensive article...

2014-07-31 23:20:55

According to relationship specialist Dr. Daniel Watter with Morris Psychological Group, most men treated for prostate cancer suffer a disruption in either libido or sexual function – or both – that may be temporary or may be long-lasting. It's important for the couple to communicate openly with each other and with his medical team both before treatment to be prepared for possible side effects and after treatment to adjust to the physical and emotional impact on their relationship....

2014-07-29 04:22:06

OXFORD, England, July 29, 2014 /PRNewswire/ -- Glide Pharmaceutical Technologies Ltd (Glide Pharma) today announced that it has taken an exclusive worldwide licence to an innovative prostate cancer diagnostic technology from FScan Ltd, a Durham University spin-out company. Under the terms of the agreement, Glide Pharma will pay an upfront fee, development and commercial milestone payments, and royalties on future product sales. Glide Pharma has also taken an option for...

2014-07-19 23:00:07

ResearchMoz.us include new market research report "United States Non-Vascular Stents Market Outlook to 2020" to its huge collection of research reports. Full report at http://www.researchmoz.us/united-states-non-vascular-stents-market-outlook-to-2020-report.html. Albany, NewYork (PRWEB) July 20, 2014 United States Non-Vascular Stents Market Outlook to 2020 Summary GlobalDatas new report, "United States Non-Vascular Stents Market Outlook to 2020", provides key market...

2014-07-16 23:10:21

For the first time ever, Prostate cancer patients can complete a survey describing how their diagnosis changed their lives. New York, NY (PRWEB) July 16, 2014 Prostate cancer disrupts men's lives in ways that are unimaginable. Now, for the first time ever, a national survey is asking men to describe their experiences regarding life after Prostate Cancer diagnosis. The National Men's Cancer Survivor support and advocacy nonprofit, Malecare Cancer Support, designed and launched...

2014-07-15 14:06:51

University of Texas M. D. Anderson Cancer Center Wide variations seen in up-front therapy versus active surveillance New research from The University of Texas MD Anderson Cancer Center is shedding light on the important role a diagnosing urologist plays in whether older men with low-risk prostate cancer receive treatment for their disease, and if so, the type of treatment they receive as a result. The findings, published in JAMA Internal Medicine, sought to examine why active...

2014-07-11 09:19:30

Harvard School of Public Health Vasectomy was associated with a small increased risk of prostate cancer, and a stronger risk for advanced or lethal prostate cancer according to a new study from Harvard School of Public Health (HSPH). The researchers found that the association remained even among men who received regular PSA screening, suggesting the increased risk of lethal cancer cannot be explained by diagnostic bias. It is the largest and most comprehensive study to date to look at the...


Latest Prostate Reference Libraries

Prostate
2013-03-04 15:21:55

The male prostate gland acts as an exocrine gland in the male reproductive system. It is a firm, partly muscular, chestnut sized gland near the neck of the urethra in males. Formation and Orientation The prostate is usually formed within the ninth week of the embryonic stage in reproductive development. The prostate can be separated into either “lobes” or “zones”. When looking at a prostate divided into zones, there are four distinct regions. The first zone is the Peripheral...

More Articles (1 articles) »
Word of the Day
mallemaroking
  • Nautical, the visiting and carousing of sailors in the Greenland ships.
This word is apparently from a confusion of two similar Dutch words: 'mallemerok,' a foolish woman, and 'mallemok,' a name for some persons among the crew of a whaling vessel.